Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
Top Cited Papers
Open Access
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 12 (2), 127-136
- https://doi.org/10.1016/s1470-2045(10)70290-4
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK ((grant numbers C8996/A8684, trial reference number CRUK/03/005))
This publication has 37 references indexed in Scilit:
- Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapyRadiotherapy and Oncology, 2010
- Comparison of patient-reported late treatment toxicity (LENT–SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapyRadiotherapy and Oncology, 2010
- Advances in radiotherapy for head and neck cancerOral Oncology, 2010
- Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long‐term survivorsHead & Neck, 2002
- Intensity modulated radiation therapy: a clinical review.The British Journal of Radiology, 2000
- Intensity-modulated radiation therapy in head and neck cancers:The Mallinckrodt experienceInternational Journal of Cancer, 2000
- Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.1999
- Parotid Sparing Study in Head and Neck Cancer Patients Receiving Bilateral Radiation Therapy: One-year ResultsJournal of Dental Research, 1997